Cargando…

Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma

Progesterone resistance can significantly restrict the efficacy of conservative treatment for patients with endometrial cancer who wish to preserve their fertility or those who suffer from advanced and recurrent cancer. SREBP1 is known to be involved in the occurrence and progression of endometrial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Xiaohong, Zhao, Tianyi, Yan, Hong, Guo, Kui, Liu, Zhiming, Wei, Lina, Lu, Wei, Qiu, Chunping, Jiang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155186/ https://www.ncbi.nlm.nih.gov/pubmed/34039951 http://dx.doi.org/10.1038/s41419-021-03762-0

Ejemplares similares

ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL
por: Ma, Xiaohong, et al.
Publicado: (2022)

Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma
por: Wei, Lina, et al.
Publicado: (2023)

Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line
por: Li, Wenzhi, et al.
Publicado: (2019)

Fatostatin ameliorates inflammation without affecting cell viability
por: Ma, Shuhe, et al.
Publicado: (2022)

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
por: Liu, Ying, et al.
Publicado: (2020)

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer [Corrigendum]
Publicado: (2022)

Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer
por: Brovkovych, Viktor, et al.
Publicado: (2018)

Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma
por: Cai, Jiayang, et al.
Publicado: (2023)

Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
por: Zhou, Yifan, et al.
Publicado: (2020)

Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer
por: van der Horst, Paul H., et al.
Publicado: (2012)

Progesterone attenuates temporomandibular joint inflammation through inhibition of NF-κB pathway in ovariectomized rats
por: Xue, Xin-Tong, et al.
Publicado: (2017)

Anti-inflammatory effects of progesterone through NF-κB and MAPK pathway in lipopolysaccharide- or Escherichia coli-stimulated bovine endometrial stromal cells
por: Cui, Luying, et al.
Publicado: (2022)

Endometrial progesterone resistance and PCOS
por: Li, Xin, et al.
Publicado: (2014)

NF-κB/HDAC1/SREBP1c pathway mediates the inflammation signal in progression of hepatic steatosis
por: Guo, Yunwei, et al.
Publicado: (2020)

Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer
por: Li, Xin, et al.
Publicado: (2019)

Forkhead transcription factor 1 inhibits endometrial cancer cell proliferation via sterol regulatory element-binding protein 1
por: Zhang, Yifang, et al.
Publicado: (2017)

Progesterone Signaling in Endometrial Epithelial Organoids
por: Hewitt, Sylvia C., et al.
Publicado: (2022)

The high concentration of progesterone is harmful for endometrial receptivity and decidualization
por: Liang, Yu-Xiang, et al.
Publicado: (2018)

SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-κB pathway activation
por: Gao, Yuyan, et al.
Publicado: (2019)

Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating TGF-β/Smad2/3 signaling pathway: Tumor-promoting effect of LPCAT1 in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2022)

Post hysteroscopic progesterone hormone therapy in the treatment of endometrial polyps
por: Li, Fangfang, et al.
Publicado: (2018)

Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2021)

Curcumin inhibits the proteolytic process of SREBP‐2 by first inhibiting the expression of S1P rather than directly inhibiting SREBP‐2 expression
por: Li, Yongnan, et al.
Publicado: (2020)

Preoperative platelet morphology parameters as prognostic predictors for endometrial malignant carcinoma stage and progesterone receptor
por: Song, Jianrong, et al.
Publicado: (2019)

Administration of progesterone on the day of oocyte retrieval to reverse accumulation of fluid in the endometrial cavity during assisted reproductive techniques
por: Cavagna, Mario, et al.
Publicado: (2014)

Paeoniflorin inhibits proliferation of endometrial cancer cells via activating MAPK and NF-κB signaling pathways
por: Zhang, Jianxin, et al.
Publicado: (2017)

RBPJ inhibits the movability of endometrial carcinoma cells by miR-155/NF-κB/ROS pathway
por: Xiao, Yufeng, et al.
Publicado: (2019)

Melatonin improves pregnancy outcomes in adenomyosis mice by restoring endometrial receptivity via NF-κB/apoptosis signaling
por: Guan, Xiaohong, et al.
Publicado: (2022)

Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
por: Kreizman-Shefer, Hila, et al.
Publicado: (2014)

Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes
por: JIANG, NING, et al.
Publicado: (2016)

Inhibition of SREBP1 sensitizes cells to death ligands
por: Eberhard, Yanina, et al.
Publicado: (2011)

The Role of NF-κB in Endometrial Diseases in Humans and Animals: A Review
por: Zdrojkowski, Łukasz, et al.
Publicado: (2023)

DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma
por: Zhou, Qing, et al.
Publicado: (2019)

Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
por: Wang, Caifeng, et al.
Publicado: (2020)

Aβ inhibits SREBP-2 activation through Akt inhibition
por: Mohamed, Amany, et al.
Publicado: (2018)

Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma
por: Shao, Ruijin
Publicado: (2013)

Reversal of angiotensin ll-induced β-cell dedifferentiation via inhibition of NF-κb signaling
por: Chen, Hong, et al.
Publicado: (2018)

Haloperidol Instigates Endometrial Carcinogenesis and Cancer Progression by the NF-κB/CSF-1 Signaling Cascade
por: Chiang, Jung-Ying, et al.
Publicado: (2022)

Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway
por: Zuo, Lian, et al.
Publicado: (2010)

Increased LDL receptor by SREBP2 or SREBP2-induced lncRNA LDLR-AS promotes triglyceride accumulation in fish
por: Cao, Xiufei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_351f3h1g9agaj58g02pfssrl5d